目的 观察注射用纤溶酶与阿司匹林（乙酰水杨酸）联合治疗脑梗死的临床效果。方法 对福建晋江市医院2011年1月-2012年12月收治的160例脑梗死患者（均发病后6 h以上入院，不适合静脉溶栓）随机分为2组。治疗组静脉滴注纤溶酶200 U加100 mg阿司匹林口服1 次/d，对照组仅口服相同剂量的阿司匹林，两组均常规口服20 mg阿托伐他汀1 次/d，共治疗2周。比较治疗前后血液流变学指标变化，以及治疗1个月、6个月后的预后。结果 治疗组肢体瘫痪较对照组明显好转，效果明显优于对照组，无明显病情加重病例。结论 注射用纤溶酶与阿司匹林联合治疗脑梗死，安全有效，值得推广应用。

Objective To observe the effect of injectable fibrinolysin and Aspirin (acetylsalicylic acid) in treatment of cerebral infarction. Methods Patients with cerebral infarction (160 cases) presenting more than 6 h after symptom onset from January 2011 to December 2012 admitted to Jinjiang Municipal Hospital were randomly divided into treatment group (injectable fibrinolysin iv ggt 200 U and acetylsalicylic acid po 100 mg) and control group (Aspirin po 100 mg). The patients in both groups were treated with atorvastatin (20 mg/d ) for 2 weeks. Results The patients in the treating group had better paralysis recovery than those in the control group. Conclusion The therapy of injectable fibrinolysin and Aspirin is effective and safe.